MetaVia Says Preclinical Tissue Distribution Study Showed Highest DA-1726 Exposure In Adipose Tissue And Prolonged Tissue Retention Through 144 Hours; Says 16-Week Topline Data Expected In Q4, 24-Week Results In Q1 2027
Share
Why It Matters
MetaVia tested a medicine called DA-1726 and found it stayed longest in fat tissue under the skin. The company will share early results later this year and more complete results in early 2027, so we'll know more about whether it actually works in people.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.